Drug Discovery for Remission of Chronic Kidney Disease
Deadline Aug 20 2020 11:59 PM (EDT)
Description

Event Date: September 25, 2020
Deadline to Submit Abstracts: August 20, 2020

You are invited to submit a poster abstract which will be displayed virtually on our website. See here for submission guidelines.

Thirty million Americans have chronic kidney disease (CKD) and over 600,000 are currently living with end stage kidney disease (ESKD), requiring dialysis or kidney transplantation to sustain their lives. However, the great majority of patients living with ESKD do not have access to kidney transplantation due to the scarcity of donor organs. Moreover, there have been few advances in effective treatments for patients living with kidney disease in the past fifty years.

This symposium will highlight the latest research on the physiological and genetic mechanisms underlying CKD, as well as novel imaging techniques and emerging biomarkers that promise improved detection and characterization of the disease. There will also be discussion of recent progress and remaining hurdles for novel ESKD treatment strategies, including kidney xenotranplantation.

To register for this event, please visit the main website at: www.nyas.org/CKD2020

Apply

Drug Discovery for Remission of Chronic Kidney Disease


Event Date: September 25, 2020
Deadline to Submit Abstracts: August 20, 2020

You are invited to submit a poster abstract which will be displayed virtually on our website. See here for submission guidelines.

Thirty million Americans have chronic kidney disease (CKD) and over 600,000 are currently living with end stage kidney disease (ESKD), requiring dialysis or kidney transplantation to sustain their lives. However, the great majority of patients living with ESKD do not have access to kidney transplantation due to the scarcity of donor organs. Moreover, there have been few advances in effective treatments for patients living with kidney disease in the past fifty years.

This symposium will highlight the latest research on the physiological and genetic mechanisms underlying CKD, as well as novel imaging techniques and emerging biomarkers that promise improved detection and characterization of the disease. There will also be discussion of recent progress and remaining hurdles for novel ESKD treatment strategies, including kidney xenotranplantation.

To register for this event, please visit the main website at: www.nyas.org/CKD2020

Apply
Deadline
Aug 20 2020 11:59 PM (EDT)